Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model

被引:63
作者
Hagenaars, Niels [2 ]
Mastrobattista, Enrico [2 ]
Glansbeek, Harrie [3 ]
Heldens, Jacco [3 ]
van den Bosch, Han [3 ]
Schijns, Virgil [3 ]
Betbeder, Didier [4 ,5 ]
Vromans, Herman [2 ,6 ]
Jiskoot, Wim [1 ]
机构
[1] Leiden Univ, LACDR, Div Drug Delivery Technol, NL-2300 RA Leiden, Netherlands
[2] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands
[3] Nobilon, NL-5830 AH Boxmeer, Netherlands
[4] Univ Lille 2, Fac Med, IFR 114, IMPRT,EA 2689,Physiol Lab, F-59045 Lille, France
[5] Univ Artois, F-62030 Arras, France
[6] Organon, Dept Pharmaceut, NL-5340 BH Oss, Netherlands
关键词
Influenza vaccination; Nasal vaccination; Whole inactivated virus; Split vaccine; Subunit vaccine; Virosomes;
D O I
10.1016/j.vaccine.2008.09.057
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations. i.e. whole inactivated virus (WIV), Split, Subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular(i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher Serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 mu g. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG I titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal slgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in Magnitude and quality Of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. it conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate Structure of these vaccine formulations. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6555 / 6563
页数:9
相关论文
共 54 条
[1]  
Ambrose Christopher S, 2006, Semin Pediatr Infect Dis, V17, P206, DOI 10.1053/j.spid.2006.08.007
[2]   Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines [J].
Asahi, Y ;
Yoshikawa, T ;
Watanabe, I ;
Iwasaki, T ;
Hasegawa, H ;
Sato, Y ;
Shimada, S ;
Nanno, M ;
Matsuoka, Y ;
Ohwaki, M ;
Iwakura, Y ;
Suzuki, Y ;
Aizawa, C ;
Sata, T ;
Kurata, T ;
Tamura, S .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :2930-2938
[3]   Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus [J].
Asahi-Ozaki, Y ;
Yoshikawa, T ;
Iwakura, Y ;
Suzuki, Y ;
Tamura, S ;
Kurata, T ;
Sata, T .
JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (02) :328-335
[4]   INACTIVATED INFLUENZA VACCINE EFFICACY - DIMINISHED ANTIGENICITY OF SPLIT-PRODUCT VACCINES IN MICE [J].
BARRY, DW ;
STATON, E ;
MAYNER, RE .
INFECTION AND IMMUNITY, 1974, 10 (06) :1329-1336
[5]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[6]   Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults [J].
Ben-Yehuda, A ;
Joseph, A ;
Zeira, E ;
Even-Chen, S ;
Louria-Hayon, I ;
Babai, I ;
Zakay-Rones, Z ;
Greenbaum, E ;
Barenholz, Y ;
Kedar, E .
JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (04) :560-567
[7]   Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines - A review and meta-analysis of the literature [J].
Beyer, WEP ;
Palache, AM ;
Osterhaus, ADME .
CLINICAL DRUG INVESTIGATION, 1998, 15 (01) :1-12
[8]   Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness [J].
Bizanov, G ;
Janakova, L ;
Knapstad, SE ;
Karlstad, T ;
Bakke, H ;
Haugen, IL ;
Haugan, A ;
Samdal, HH ;
Haneberg, B .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 61 (06) :503-510
[9]   Induction of secretory immunity and memory at mucosal surfaces [J].
Brandtzaeg, Per .
VACCINE, 2007, 25 (30) :5467-5484
[10]   Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin [J].
Bright, Rick A. ;
Carter, Donald M. ;
Daniluk, Shannon ;
Toapanta, Franklin R. ;
Ahmad, Attiya ;
Gavrilov, Victor ;
Massare, Mike ;
Pushko, Peter ;
Mytle, Nutan ;
Rowe, Thomas ;
Smith, Gale ;
Ross, Ted M. .
VACCINE, 2007, 25 (19) :3871-3878